Article History
Accepted: 26 July 2022
First Online: 31 August 2022
Competing interests
: A.F.T. has received consulting fees from CinCor Pharma and PhaseBio. A.V. reports consulting activities with Mineralys Therapeutics, Corcept Therapeutics, and HRA Pharma, all unrelated to the current work. J.Y. declares no competing interests.